MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma.
| Autor: | Gu, Yaoyao1,2 (AUTHOR), Hu, Xiaoxiao1,2,3 (AUTHOR), Liu, Xiaowei1,2 (AUTHOR), Cheng, Cheng1,2 (AUTHOR), Chen, Kai1,2 (AUTHOR), Wu, Yeming1,2,4 (AUTHOR), Wu, Zhixiang1,2,4 (AUTHOR) wuzhixiang@xinhuamed.com.cn |
|---|---|
| Zdroj: | BMC Cancer. 7/7/2021, Vol. 21 Issue 1, p1-14. 14p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|